Preclinical Strategy

Rigorous preclinical research is the foundation every later decision rests on — and where avoidable mistakes get expensive. We help you design studies that survive investor, CRO, and regulatory scrutiny, choose and manage the right vendors, and turn data into defensible decisions.

Study design & power analysis

Endpoints chosen to defend the specific claim (not convenience); pre-specified analysis plans; sample sizes powered for realistic effect sizes; blinding and randomization; controls for cage, cohort, site, scanner, and operator variance.

Endpoint strategy

Tying endpoints to the clinical/translational question so results mean what you’ll later need them to mean.

CRO & vendor management

Shortlist and vet vendors, review SOWs, and provide study oversight so the work actually delivers what you paid for.

Data analysis & figure generation

Clean, reproducible analysis; publication- and submission-ready figures.

Data interpretation

An honest read of what the data supports — and what it doesn’t — before you build a story on it.